(Q36150125)

12 August 2017

Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants (English)

1 reference

multicenter clinical trial

12 August 2017

0 references

Duchenne muscular dystrophy

1 reference

Chiara Passarelli

14

0 references

Volker Straub

8

object named as

Volker Straub

1 reference

12 August 2017

15

Hanns Lochmüller

1 reference

12 August 2017

12

Mireille Claustres

1 reference

12 August 2017

Sylvie Tuffery-Giraud

object named as

Sylvie Tuffery-Giraud

1 reference

12 August 2017

Annemieke Aartsma-Rus

19

object named as

Annemieke M Aartsma-Rus

1 reference

12 August 2017

20

Jan J G M Verschuuren

1 reference

12 August 2017

21

Peter Ac 't Hoen

1 reference

12 August 2017

Janneke C van den Bergen

1

1 reference

12 August 2017

Monika Hiller

2

1 reference

12 August 2017

Stefan Böhringer

3

1 reference

12 August 2017

Linda Vijfhuizen

4

1 reference

12 August 2017

Hendrika B Ginjaar

5

1 reference

12 August 2017

Amina Chaouch

6

1 reference

12 August 2017

Kate Bushby

7

1 reference

12 August 2017

Mariacristina Scoto

9

1 reference

12 August 2017

Sebahattin Cirak

10

1 reference

12 August 2017

Véronique Humbertclaude

11

1 reference

12 August 2017

Chiara Scotton

13

1 reference

12 August 2017

Francesco Muntoni

16

1 reference

12 August 2017

Alessandra Ferlini

18

1 reference

12 August 2017

Pietro Spitali

22

1 reference

12 August 2017

language of work or name

English

0 references

publication date

4 December 2014

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

12 August 2017

1 reference

12 August 2017

86

1 reference

12 August 2017

10

1 reference

12 August 2017

1060-1065

1 reference

LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602257

Alterations in osteopontin modify muscle size in females in both humans and mice.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602257

Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602257

SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602257

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602257

Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602257

Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602257

Base-pair neutral homozygotes can be discriminated by calibrated high-resolution melting of small amplicons

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602257

Glucocorticoid corticosteroids for Duchenne muscular dystrophy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602257

Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602257

Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602257

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602257

Functional improvement of dystrophic muscle by myostatin blockade.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4602257

23 September 2018

The muscular dystrophies

1 reference

12 December 2020

Inhibition of skeletal muscle satellite cell differentiation by transforming growth factor-beta

1 reference

12 December 2020

Motor and respiratory heterogeneity in Duchenne patients: Implication for clinical trials

1 reference

12 December 2020

1 reference

12 December 2020

Loss of myostatin attenuates severity of muscular dystrophy in mdx mice

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP-2014-308409

1 reference

release_yt53tt7gybhizo5kh7dtop4caq

12 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yt53tt7gybhizo5kh7dtop4caq

24 November 2022

mapped directly with Wikidata item

1 reference

12 August 2017

PubMed publication ID

25476005

1 reference